Financials
- Market Capitalization 7.97 M
- Employee N/A
- Founded 2021
- CEO N/A
- Website www.aspirebiolabs.com
- Headquarter Cayman Islands
- FIGI BBG015STV133
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.32
ratio cours/chiffre d'affaires
1 271.75
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4863 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 8.47 USD | +1.56% | +0.24% | +63.51% | -10.92% | 8.05 M USD | ||
| 4870 | ELOX Eloxx Pharmaceuticals, Inc. | 11.20 USD | -1.32% | -3.70% | -24.58% | +12.00% | 7.71 M USD | ||
| 4886 | BOLT Bolt Biotherapeutics, Inc. - Common Stock | 4.01 USD | +6.08% | -4.52% | -15.40% | -32.61% | 7.71 M USD | ||
| 4887 | AEON AEON Biopharma, Inc. Class A Common Stock | 0.31 USD | -3.13% | -56.34% | -55.07% | -70.19% | 8.16 M USD |